E-mail: info@arium.pt | Tlf: (+351) 217 956 912
Site logo
Sticky header logo
Mobile logo
  • Our DNA
  • Our Solutions
    • In Vitro Diagnostics
    • Life Sciences
    • Veterinary
    • Equipment
  • News
  • Schedule
  • Contacts
  • EN
  • PT

Author Archives: buzzhost

News BÜHLMANN fCAL® turbo – Automated Immunoturbidimetric Trial for Fecal Calprotectin dosage
9 October, 2019in News 0 Comments 0 Likes

BÜHLMANN fCAL® turbo – Automated Immunoturbidimetric Trial for Fecal Calprotectin dosage

Fecal calprotectin can be dosed with BÜHLMANN fCAL® turbo kit on different clinical chemistry platforms, allowing consolidation and improvement of lab workflow. This application allows random sample access, a quick

by buzzhost
News Theradiag Lisa Tracker: Monitoring of Biological Drugs
9 October, 2019in News 0 Comments 0 Likes

Theradiag Lisa Tracker: Monitoring of Biological Drugs

ANTICIPATION, OPTIMIZATION AND ORIENTATION in the treatment with biological drugs of patients with cancer or chronic inflammatory diseases. Currently, about 70% of new drugs are biological and it seems to be

by buzzhost
News New partner in Immunoallergology – Macro Array Diagnostics GmbH
9 October, 2019in News 0 Comments 0 Likes

New partner in Immunoallergology – Macro Array Diagnostics GmbH

We are pleased to inform you that Macro Array Diagnostics GmbH is our latest partner in Immunology. Allergy Explorer, ALEX, is the first multiplex in vitro allergy test with the widest

by buzzhost

Informations

  • Our DNA
  • News
  • Schedule

Our solutions

  • In Vitro Diagnostics
  • Life Sciences
  • Veterinary
  • Equipment

Subscribe to our newsletter

Follow us

Arium 2019 © Todos os direitos reservados
div#stuning-header .dfd-stuning-header-bg-container {background-image: url(https://arium.pt/wp-content/uploads/2019/03/arium-agenda_layer.png);background-color: #822433;background-size: cover;background-position: center center;background-attachment: scroll;background-repeat: no-repeat;}#stuning-header div.page-title-inner {min-height: 300px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}